Phase 4
Completed N=162
Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora
Bacterial Conjunctivitis
Source: ClinicalTrials.gov NCT00312338 ↗
Enrolled (actual)
162
Serious AEs
0.0%
Results posted
Feb 2010
Primary outcomePrimary: Susceptability Changes in Streptococcus Pneumoniae Distal to the Site of Instillation — 0; 0; 0; 0 Percent of resistant isolates
Summary
Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Susceptability Changes in Streptococcus Pneumoniae Distal to the Site of Instillation |
0; 0; 0; 0 | — |
| PRIMARY Susceptability Changes in Staphylococcus Aureus Distal to the Site of Instillation |
8.3; 0; 0; 0 | — |
| PRIMARY Susceptability Changes in Haemophilus Influenzae Distal to the Site of Instillation |
0; 0; 0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Patients from 1 to 13 years of age that have diagnosis of bacterial conjunctivitis in either or both eyes (for 2 days
Data sourced from ClinicalTrials.gov (NCT00312338). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.